Emil D. Kakkis, President & CEO at Ultragenyx Pharmaceutical Inc. (RARE), sold 20,000 shares at $67.39 ($1.4M) on 2016-08-15, disclosed to the SEC on 2016-08-17.
Open-market sale of $1.4M RARE by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.39 | 13,903 | $937K | 69.3% |
| 2 | $68.12 | 6,097 | $415K | 30.7% |
| Total | $67.61 avg | 20,000 | $1.4M | 100% |
| Filing → |
| RARE | SELL | 2024-12-31 | $990K | — | Filing → |
| RARE | SELL | 2024-12-11 | $414K | — | Filing → |
| RARE | SELL | 2024-09-05 | $1.1M | — | Filing → |